Welcome to the December edition of i2P-Information to Pharmacists.
As we wind down in 2013 for the holiday period we will be filing some updates, but at a little more leisurely pace.
Where has the year gone?
Certainly the rate of change for 2013 has been more than hectic and there has been little time to organise thoughts and set appropriate directions.
This is the season for hard negotiations for the 6CPA but there is little left to squeeze.
Pharmacy has had the equivalent of bariatric surgery.
Government has taken it all, as usual.
As current price changes work their way through the pharmacy cash flow cycle, for some there will be insufficient- and heartburn.
Crunch time is that there will be more bankruptcies over 2014.
Media reports that some pharmacies have received free shop refits as a form of payment for purchasing a specific generic drug range is certainly not obvious, as the average pharmacy is in need of some renovation or repair and looking a bit jaded.
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
Volume 4 Number 5
Volume 4 Number 6
Volume 4 Number 7
Volume 4 Number 8
Volume 4 Number 9
Volume 4 Number 10
Volume 4 Number 11
Volume 5 Number 1
Volume 5 Number 2
Volume 5 Number 3
Volume 5 Number 4
Volume 5 Number 5
Volume 5 Number 6
Volume 5 Number 7
Volume 5 Number 8
Volume 5 Number 9
Volume 5 Number 10
Volume 5 Number 11
Editing and Researching news and stories about global and local Pharmacy Issues
Source: AAP NewsWire
Source: AAP NewsWire
The wind farm set to power Sydney's desalination plant will begin operation this week and its owner Infigen Energy says similar projects will drive the company's growth.
The 67-turbine Capital wind farm, near Bungendore, east of Canberra, will be opened on Wednesday.
It will be the largest wind farm in NSW and is more than five times the size of any other wind farm in the state, Infigen says.
The wind farm has a capacity of 140.7 megawatts (MW) and its total output could power about 60,000 homes, although average output is expected to be slightly more than one third of full capacity.
Under a 20-year contract signed last year, the majority of Capital wind farm's output will be used by Sydney Water to power its desalination plant at Kurnell, in the south suburbs of Sydney.
Infigen managing director Miles George said the desalination plant would use 40MW of electricity when it began operating this summer, and that any left over power generated by the wind farm would go into the national electricity grid.
The opening marks a major milestone for Infigen, formerly known as Babcock & Brown Wind Partners until a management internalisation in April this year.
With four operational Australian wind farms on its books, another under construction and a further 12 in its project pipeline, the company says the federal government's renewable energy targets will be the main driver for its future growth.
A major component would also be the supply of power to major infrastructure such as desalination plants, George said.
"We expect that desalination plants will be a significant part of our business, going forward," he told reporters.
"It's expected that there will be half a dozen or so still to come around the country.
"From our point of view, having large long-term customers who, like Sydney Water, are seeking to operate their plants in a carbon-neutral fashion ... we think is a great prospect for our business."
Plans to sell Infigen's wind farm assets in the United States, Germany and France are continuing on track, George said.
The company intends to use the proceeds to pay down debt and focus primarily on the Australian renewable energy sector.
Infigen said in August the sale process was expected to take six months and possibly longer in the US.
"We are well into that process now, and the processes are going very well, there's no change to our timetable," George said.
"We mentioned at the outset that there was very strong interest from all three jurisdictions for those assets and that remains the case."
The company would provide a trading update for the financial year-to-date at its annual general meeting next week, he said.Return to home